The University of Southampton
University of Southampton Institutional Repository

Real-life comparison of beclometasone dipropionate as an extrafine- or larger- particle formulation for asthma

Real-life comparison of beclometasone dipropionate as an extrafine- or larger- particle formulation for asthma
Real-life comparison of beclometasone dipropionate as an extrafine- or larger- particle formulation for asthma
Background
Beclometasone dipropionate is an inhaled corticosteroid (ICS) available in both extrafine and larger-particle hydrofluoroalkane formulations. Extrafine beclometasone has greater small airway distribution and inhalation technique tolerance than larger-particle beclometasone; therefore, its use may be associated with improved asthma outcomes at population levels. The study objective was to compare real-life effectiveness of extrafine and larger-particle beclometasone.

Methods
Retrospective matched cohort study including primary care patients with asthma (ages 12–60 and non-smokers 61–80 years) prescribed extrafine or larger-particle beclometasone by metered-dose inhaler. We studied patients receiving their first ICS (initiation population, n = 11,289) or switched from another ICS without dose change (switch population, n = 19,065). The extrafine and larger-particle beclometasone cohorts were matched in each population for demographic and database measures of asthma control during a baseline year; and endpoints assessed during 1 outcome year were adjusted for residual confounding factors.

Results
The odds of no loss of asthma control (no asthma-related hospital attendance, consultation for lower respiratory tract infection, or oral corticosteroids) were significantly higher in the extrafine beclometasone cohorts of both initiation population (adjusted odds ratio [aOR] 1.12; 95% CI 1.02–1.23) and switch population (aOR 1.10; 95% CI 1.01–1.19). The odds of better adherence to ICS therapy were also significantly higher in both extrafine beclometasone cohorts (initiation population, aOR 1.64; 95% CI 1.52–1.75 and switch population, aOR 1.35; 95% CI 1.27–1.43).

Conclusions
These findings are consistent with the hypothesis that delivery of beclometasone in extrafine particle size produces real-life asthma treatment benefits.

asthma control, beclometasone, extrafine particle, inhaler, lung deposition
987-1000
Price, D.
7534eb51-9b20-4840-9604-f34a428c855c
Thomas, M.
997c78e0-3849-4ce8-b1bc-86ebbdee3953
Haughney, J.
f0a7751e-fed5-434e-8caa-31c1488fb3c6
Lewis, R.A.
0b1e3357-f3d0-4b17-90bb-ef4c562759a0
Burden, A.
8f6413f0-daaa-4e59-9a83-7de5f0f3315d
von Ziegenweidt, J.
d856a24c-dd62-409d-9f9a-1478938c41d6
Chrisholm, A.
86a191de-efa4-4f4a-815c-94bace35cf42
Hillyer, E.V.
9f6609c8-3e76-476e-8294-d035ecab0d1f
Corrigan, C.J.
d762d0f0-108f-43ac-8160-ac6b3f0b69f9
Price, D.
7534eb51-9b20-4840-9604-f34a428c855c
Thomas, M.
997c78e0-3849-4ce8-b1bc-86ebbdee3953
Haughney, J.
f0a7751e-fed5-434e-8caa-31c1488fb3c6
Lewis, R.A.
0b1e3357-f3d0-4b17-90bb-ef4c562759a0
Burden, A.
8f6413f0-daaa-4e59-9a83-7de5f0f3315d
von Ziegenweidt, J.
d856a24c-dd62-409d-9f9a-1478938c41d6
Chrisholm, A.
86a191de-efa4-4f4a-815c-94bace35cf42
Hillyer, E.V.
9f6609c8-3e76-476e-8294-d035ecab0d1f
Corrigan, C.J.
d762d0f0-108f-43ac-8160-ac6b3f0b69f9

Price, D., Thomas, M., Haughney, J., Lewis, R.A., Burden, A., von Ziegenweidt, J., Chrisholm, A., Hillyer, E.V. and Corrigan, C.J. (2013) Real-life comparison of beclometasone dipropionate as an extrafine- or larger- particle formulation for asthma. Respiratory Medicine, 107, 987-1000. (doi:10.1016/j.rmed.2013.03.009). (PMID:23643486)

Record type: Article

Abstract

Background
Beclometasone dipropionate is an inhaled corticosteroid (ICS) available in both extrafine and larger-particle hydrofluoroalkane formulations. Extrafine beclometasone has greater small airway distribution and inhalation technique tolerance than larger-particle beclometasone; therefore, its use may be associated with improved asthma outcomes at population levels. The study objective was to compare real-life effectiveness of extrafine and larger-particle beclometasone.

Methods
Retrospective matched cohort study including primary care patients with asthma (ages 12–60 and non-smokers 61–80 years) prescribed extrafine or larger-particle beclometasone by metered-dose inhaler. We studied patients receiving their first ICS (initiation population, n = 11,289) or switched from another ICS without dose change (switch population, n = 19,065). The extrafine and larger-particle beclometasone cohorts were matched in each population for demographic and database measures of asthma control during a baseline year; and endpoints assessed during 1 outcome year were adjusted for residual confounding factors.

Results
The odds of no loss of asthma control (no asthma-related hospital attendance, consultation for lower respiratory tract infection, or oral corticosteroids) were significantly higher in the extrafine beclometasone cohorts of both initiation population (adjusted odds ratio [aOR] 1.12; 95% CI 1.02–1.23) and switch population (aOR 1.10; 95% CI 1.01–1.19). The odds of better adherence to ICS therapy were also significantly higher in both extrafine beclometasone cohorts (initiation population, aOR 1.64; 95% CI 1.52–1.75 and switch population, aOR 1.35; 95% CI 1.27–1.43).

Conclusions
These findings are consistent with the hypothesis that delivery of beclometasone in extrafine particle size produces real-life asthma treatment benefits.

Full text not available from this repository.

More information

Published date: 3 May 2013
Keywords: asthma control, beclometasone, extrafine particle, inhaler, lung deposition
Organisations: Primary Care & Population Sciences

Identifiers

Local EPrints ID: 352713
URI: https://eprints.soton.ac.uk/id/eprint/352713
PURE UUID: ac949e40-50a7-43a6-b6dc-3260d161dda7

Catalogue record

Date deposited: 20 May 2013 12:23
Last modified: 16 Jul 2019 21:33

Export record

Altmetrics

Contributors

Author: D. Price
Author: M. Thomas
Author: J. Haughney
Author: R.A. Lewis
Author: A. Burden
Author: J. von Ziegenweidt
Author: A. Chrisholm
Author: E.V. Hillyer
Author: C.J. Corrigan

University divisions

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of https://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×